Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001132336) titled 'A Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending and Multiple-Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of WIN027 in Healthy Adult Participants' on Sept. 11.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Primary Sponsor: Windward Bio 27 AG
Condition:
Asthma
Chronic Obstructive Pulmonary Disease
Asthma
Chronic Obstructive Pulmonary Disease
Respiratory - Asthma
Respiratory - Chronic obstructive pulmonary disease
Intervention:
The study drug WIN027 is given as a subcutaneous...